Paper38519366
Emerging roles of TBK1 in cancer immunobiology.
Miranda A and 2 others. Trends Cancer, 2024. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Emerging roles of TBK1 in cancer immunobiology. Papers, record 38519366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38519366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Tumor Microenvironment | Major topic |
| Immunity, Innate | Major topic |
| Humans | |
| Animals | |
| Tumor Escape | |
| Signal Transduction | |
| Autophagy |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R37 CA283560 | NCI NIH HHS | United States | R37CA283560 | PubMed and NIH |
Source NIH RePORTER
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24449872 | Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24449872 | PubMed |
| 2 | 30146158 | TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging. | Cell | 2018 | https://conductscience.org/library/papers/30146158 | PubMed |
| 3 | 29319049 | Mechanisms of resistance to immune checkpoint inhibitors. | Br J Cancer | 2018 | https://conductscience.org/library/papers/29319049 | PubMed |
| 4 | 32968282 | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | Nature | 2020 | https://conductscience.org/library/papers/32968282 | PubMed |
| 5 | 35074921 | Myeloid cell TBK1 restricts inflammatory responses. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35074921 | PubMed |
| 6 | 30842653 | Structural basis of STING binding with and phosphorylation by TBK1. | Nature | 2019 | https://conductscience.org/library/papers/30842653 | PubMed |
| 7 | 28187290 | Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. | Cell | 2017 | https://conductscience.org/library/papers/28187290 | PubMed |
| 8 | 29301958 | A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. | Science | 2018 | https://conductscience.org/library/papers/29301958 | PubMed |
| 9 | 24062311 | Loss of TBK1 induces epithelial-mesenchymal transition in the breast cancer cells by ERα downregulation. | Cancer Res | 2013 | https://conductscience.org/library/papers/24062311 | PubMed |
| 10 | 25858804 | Immune checkpoint blockade: a common denominator approach to cancer therapy. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25858804 | PubMed |
| 11 | 31792381 | TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis. | Nat Cell Biol | 2019 | https://conductscience.org/library/papers/31792381 | PubMed |
| 12 | 10581243 | NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. | EMBO J | 1999 | https://conductscience.org/library/papers/10581243 | PubMed |
| 13 | 28356390 | The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. | J Exp Med | 2017 | https://conductscience.org/library/papers/28356390 | PubMed |
| 14 | 36634707 | Targeting TBK1 to overcome resistance to cancer immunotherapy. | Nature | 2023 | https://conductscience.org/library/papers/36634707 | PubMed |
| 15 | 30290124 | Myeloid TBK1 Signaling Contributes to the Immune Response to Influenza. | Am J Respir Cell Mol Biol | 2019 | https://conductscience.org/library/papers/30290124 | PubMed |
| 16 | 22619329 | Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22619329 | PubMed |
| 17 | 30482939 | TBK1 and IKKε restrain cell death. | Nat Cell Biol | 2018 | https://conductscience.org/library/papers/30482939 | PubMed |
| 18 | 34518217 | TBK1 and IKKε act like an OFF switch to limit NLRP3 inflammasome pathway activation. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34518217 | PubMed |
| 19 | 32962465 | Targeting TANK-binding kinase 1 (TBK1) in cancer. | Expert Opin Ther Targets | 2020 | https://conductscience.org/library/papers/32962465 | PubMed |
| 20 | 30778252 | Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. | Nat Immunol | 2019 | https://conductscience.org/library/papers/30778252 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979158 | Closing the adaptive window: immune-metabolic strategies to constrain melanoma therapy resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42979158 | PubMed |
| 42851781 | Minding the gates: dual cell-autonomous and non-cell-autonomous mechanisms of TBK1 in ALS/FTD. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42851781 | PubMed |
| 42794728 | Expanding Synthetic Lethality in DNA Damage Response-Defective Cancers Through Stress Phenotype-Guided Kinase Targeting. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794728 | PubMed |
| 42768102 | Convergent TBK1 loss of function drives gasdermin E dependent pyroptosis and motor neuron degeneration across ALS genotypes. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/42768102 | PubMed |
| 42719252 | Tumor microenvironment and signaling pathways in melanoma brain metastasis. | Ann Transl Med | 2026 | https://conductscience.org/library/papers/42719252 | PubMed |
| 42426285 | A micropeptide encoded by the lncRNA USP30-AS1 promotes tumor growth by attenuating cGAS-STING-type I IFN signaling in macrophages. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42426285 | PubMed |
| 41950925 | Selective degradation of TBK1 uncovers mechanistic insights into blocking ccRCC progression. | Cell Chem Biol | 2026 | https://conductscience.org/library/papers/41950925 | PubMed |
| 41879499 | Natural Products as Autophagy-related Protein Kinase Inhibitors: A Future Promising Anticancer from Nature. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41879499 | PubMed |
| 41376337 | CD47 blockade enhances cisplatin sensitivity by inhibiting DNA repair gene expression. | Acta Biochim Biophys Sin (Shanghai) | 2025 | https://conductscience.org/library/papers/41376337 | PubMed |
| 41315176 | Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/41315176 | PubMed |
| 40966363 | Microglial TBK1 Signaling Promotes Breast Cancer Brain Metastasis. | Cancer Res | 2026 | https://conductscience.org/library/papers/40966363 | PubMed |
| 40833415 | Macrophage TBK1 signaling drives the development and outgrowth of breast cancer brain metastasis. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40833415 | PubMed |
| 40808675 | Shikonin as a therapeutic agent in renal cell carcinoma: insights from TEK-related causal association with glaucoma. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40808675 | PubMed |
| 40484646 | Targeting TBK1 potentiates oncolytic virotherapy via amplifying ICAM1-mediated NK cell immunity in chemo-resistant colorectal cancer. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40484646 | PubMed |
| 40076567 | TANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076567 | PubMed |
| 39871363 | Role of nasal microbiota in regulating host anti-influenza immunity in dogs. | Microbiome | 2025 | https://conductscience.org/library/papers/39871363 | PubMed |
| 39279883 | Mechanism of TBK1 activation in cancer cells. | Cell Insight | 2024 | https://conductscience.org/library/papers/39279883 | PubMed |
| 39086134 | Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer. | Mol Ther | 2024 | https://conductscience.org/library/papers/39086134 | PubMed |
| 38607079 | ZO-1 Regulates Hippo-Independent YAP Activity and Cell Proliferation via a GEF-H1- and TBK1-Regulated Signalling Network. | Cells | 2024 | https://conductscience.org/library/papers/38607079 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SIK1 | 150094 | PubTator's text mining | https://conductscience.org/library/genes/150094 | NCBI Gene |
| TBK1 | 29110 | PubTator's text mining | https://conductscience.org/library/genes/29110 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38519366
GET https://conductscience.org/api/papers/v1/38519366/references?page=2